We are excited to welcome back Neurocarrus as a Bio Nebraska member.
Neurocarrus is a biotech company developing a novel drug technology to safely disrupt pain signals without risk of addiction or other systemic effects. Neurocarrus was founded in Lincoln, Nebraska by prominent research scientists in the field of protein engineering and led by a strong management team with expertise in business, biotechnology and medicine. Since inception, the company has raised $1.05M used to generate extensive in vitro and in vivo data supporting the efficacy of N-001 and to manage intellectual property.